Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01680770 · ClinicalTrials.gov registry record

Use of Ultrasonography to Determine Fluid-responsiveness for Shock in a Population of Intensive Care Unit Patients

A clinical trial of Hypotension, sponsored by University of Chicago.

Active
Registry status
124
Enrollment target
1
Study location

NCT01680770: Active study of Hypotension, sponsored by University of Chicago.

NCT01680770 is a study of Hypotension that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 124 participants, above the 70-participant average among 12 other Hypotension trials with a reported enrollment target (77% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01680770, a study of Hypotension, is active but no longer recruiting, sponsored by University of Chicago.

ACTIVE NOT RECRUITING
Registry status
124 participants
Enrollment target
1
Study location

Study Summary

The objective of our study is to determine the correlation of transthoracic ultrasonographic indices of fluid responsiveness to changes in direct measures of cardiac output and to compare them to other established predictors of fluid responsiveness such as central venous pressure variation, systolic arterial pressure variation and pulse pressure variation in a broad population of patients. Hypothesis: There will be a significant difference in the inferior vena cava respiratory variation and subclavian vein respiratory variation between responders and non-responders to intravenous fluid challenge in a broad population of patients with shock.

Primary Outcome

Patients will be divided into responder and non-responder groups based on an increase in cardiac output of greater than or equal to 15% as measured by thermodilution from a right heart catheter in response to a one liter normal saline fluid bolus.

Conditions Studied

Study Locations (1)

Illinois

  • The University of Chicago Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2010-06
Est. Completion 2026-08
University of Chicago

796 total trials

What the registry record for NCT01680770 still lists

NCT01680770 is an observational study that tracks outcomes without assigning an intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, above the 70-participant average among 12 other Hypotension trials with a reported enrollment target (77% higher).

The record links to 1 condition, with Hypotension appearing as the primary indexed condition, and to 0 interventions.

NCT01680770 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT01680770 about?

NCT01680770 is a clinical study titled "Use of Ultrasonography to Determine Fluid-responsiveness for Shock in a Population of Intensive Care Unit Patients". The objective of our study is to determine the correlation of transthoracic ultrasonographic indices of fluid responsiveness to changes in direct measures of cardiac output and to compare them to other established predictors of fluid responsiveness such as central venous pressure variation, systolic...

What is the current status of trial NCT01680770?

This trial is currently active not recruiting. The enrollment target is 124 participants. The study started on 2010-06. Estimated completion is 2026-08.

What conditions does trial NCT01680770 study?

This clinical trial studies the following conditions: Hypotension.

Who is sponsoring clinical trial NCT01680770?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01680770 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypotension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01680770's enrollment target sits among peer trials

124 3rd of 12 higher than 10 of 12 other Hypotension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypotension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523014 · 124 participants · Phase 2

    Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

  • NCT02670707 · 124 participants · Phase 3

    Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

  • NCT02830724 · 124 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

  • NCT04748809 · 124 participants · NA

    Effect of Anti-inflammatory Diet in Rheumatoid Arthritis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01680770, the US trial registry maintained by the National Library of Medicine. NCT01680770 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.